LU38816A1 - - Google Patents

Info

Publication number
LU38816A1
LU38816A1 LU38816DA LU38816A1 LU 38816 A1 LU38816 A1 LU 38816A1 LU 38816D A LU38816D A LU 38816DA LU 38816 A1 LU38816 A1 LU 38816A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU38816A1 publication Critical patent/LU38816A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
LU38816D 1959-06-22 1960-06-14 LU38816A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US821720A US2966443A (en) 1959-06-22 1959-06-22 Trivalent poliomyelitis live virus vaccine

Publications (1)

Publication Number Publication Date
LU38816A1 true LU38816A1 (en) 1960-08-16

Family

ID=25234127

Family Applications (1)

Application Number Title Priority Date Filing Date
LU38816D LU38816A1 (en) 1959-06-22 1960-06-14

Country Status (5)

Country Link
US (1) US2966443A (en)
BE (1) BE591268A (en)
ES (1) ES258463A1 (en)
FR (1) FR668M (en)
LU (1) LU38816A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147185A (en) * 1959-09-10 1964-09-01 Merck & Co Inc Process for purifying viral substances and composition
GB896439A (en) * 1959-12-28 1962-05-16 Glaxo Lab Ltd Cellulose derivatives useful as anion-exchange materials and their application
US3244590A (en) * 1960-12-23 1966-04-05 Rutgers Res And Educational Fo Polyenic compounds and procedures related thereto
DE1157734B (en) * 1961-08-16 1963-11-21 Behringwerke Ag Process for the production of stable, orally administered poliomyelitis virus preparations
US3143473A (en) * 1961-08-16 1964-08-04 Behringwerke Ag Stable, solid, oral live antipoliomyelitis vaccine compositions and process for preparing them
US3128229A (en) * 1961-10-05 1964-04-07 Baylor Medical Foundation Stabilization of viral vaccine and inactivation of adventitious tissue culture contaminants therein
GB1015251A (en) * 1963-03-12 1965-12-31 Glaxo Lab Ltd Aqueous pharmaceutical compositions in capsule form
GB1171125A (en) * 1966-06-08 1969-11-19 Glaxo Lab Ltd Improvements in or relating to Injectable Preparations
MY128159A (en) * 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination

Also Published As

Publication number Publication date
FR668M (en) 1961-07-10
BE591268A (en) 1960-11-28
ES258463A1 (en) 1960-11-16
US2966443A (en) 1960-12-27

Similar Documents

Publication Publication Date Title
AT227430B (en)
AT219274B (en)
FR668M (en)
AT213197B (en)
JPS374367B1 (en)
FI40728B (en)
AT213532B (en)
AT213304B (en)
FR1601707A (en)
AT219961B (en)
AT219811B (en)
AT219930B (en)
BE575321A (en)
BE575800A (en)
BE503885A (en)
BE549973A (en)
BE461618A (en)
BE503570A (en)
SE315013B (en)
NL7000689A (en)
NL6515814A (en)
NL258643A (en)
NL257607A (en)
NL255089A (en)
NL254547A (en)